Steve Awad | Director, Global Life Sciences
North Highland

Steve Awad, Director, Global Life Sciences, North Highland

Steve is a Director within North Highland's Global Life Sciences vertical, co-leading its Cell & Gene therapy practice. He is a seasoned supply chain and technical operations leader, with 15 years of experience spanning leadership roles within Celgene (a Bristol Myers Squibb company), Johnson & Johnson, and in biopharma management consulting. He combines deep technical, scientific, and business acumen to accelerate R&D productivity and transform supply chains. Steve’s present focus is on advancing the 'art of the possible' to deliver life-changing therapies faster, more affordably, and at scale--unlocking the promise of cell & gene therapies.

Appearances:



Advanced Therapies USA 2025 - Day 1 @ 14:55

Scaling to one million patients: Cross-industry lessons for cell & gene therapy

Gene-modified cell therapies remain trapped in a high-cost, low-throughput paradigm, with ~40,000 patients treated to date versus the million-plus we must reach in the next decade. Solving the challenge demands new thinking. By fusing advanced analytics and agentic AI with proven playbooks from retail/CPG, automotive, agriculture, and fashion industries, we can compress vein-to-vein time, reduce costs, and enable quality at scale. 

This session distils those insights into a five-step roadmap—people, process, data, tech, culture—to develop a scalable, adaptive value chain ready for the next million patients.

Gene-modified cell therapies remain trapped in a high-cost, low-throughput paradigm, with ~40,000 patients treated to date versus the million-plus we must reach in the next decade. Solving the challenge demands new thinking. By fusing advanced analytics and agentic AI with proven playbooks from retail/CPG, automotive, agriculture, and fashion industries, we can compress vein-to-vein time, reduce costs, and enable quality at scale. 

This session distils those insights into a five-step roadmap—people, process, data, tech, culture—to develop a scalable, adaptive value chain ready for the next million patients.

 

last published: 10/Jul/25 18:55 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604